Listed below are some of the biotech stocks that have shown notable activity in pre-market trading Wednesday, as of 8.10 a.m. ET.
In the Green
Cellectar Biosciences, Inc. (CLRB) is up over 57% at $0.44.Sharps Technology, Inc. (STSS) is up over 52% at $5.70.Sagimet Biosciences Inc. (SGMT) is up over 20% at $4.39.NanoViricides, Inc. (NNVC) is up over 9% at $1.64.Citius Pharmaceuticals, Inc. (CTXR) is up over 9% at $0.95.Agenus Inc. (AGEN) is up over 8% at $5.43.Meihua International Medical Technologies Co., Ltd. (MHUA)is up over 8% at $0.54.Aytu BioPharma, Inc. (AYTU) is up over 8% at $1.68.Nautilus Biotechnology, Inc. (NAUT) is up over 8% at $0.83.Unicycive Therapeutics, Inc. (UNCY) is up over 8% at $0.83.Carisma Therapeutics, Inc. (CARM) is up over 7% at $0.19.Perspective Therapeutics, Inc. (CATX) is up over 5% at $3.30.Tiziana Life Sciences Ltd (TLSA) is up over 7% at $1.53.Rani Therapeutics Holdings, Inc. (RANI) is up over 6% at $0.59.Applied DNA Sciences, Inc. (APDN) is up over 6% at $5.42.Corvus Pharmaceuticals, Inc. (CRVS) is up over 5% at $4.35.60 Degrees Pharmaceuticals, Inc. (SXTP) is up over 5% at $3.07.ESSA Pharma Inc. (EPIX) is up over 5% at $1.80.KALA BIO, Inc. (KALA) is up over 5% at $4.31. In the Red
For comments and feedback contact: editorial@rttnews.com
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.